Maryam Yousefi

Maryam Yousefi

Auto-generated profile, based on publicly available information

Maryam Yousefi

Department of Obstetrics and Gynecology, School of Medicine, Qom University of Medical Sciences, Qom, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2024 in Journal of Obstetrics, Gynecology and Cancer Research
Verified
Journal Article
Open access
PDF file
SASeyed Mojtaba Alavi
Seyed Mojtaba Alavi
MAMohammad Hosein Arjmandnia
Mohammad Hosein Arjmandnia
MFMeysam Feizollahjani
Meysam Feizollahjani
ENEnayatollah Noori
Enayatollah Noori
MYMaryam Yousefi
Maryam Yousefi
Background & Objective: Placenta Accreta Spectrum (PAS) is a condition in pregnant women where trophoblastic tissue attaches abnormally to the uterus myometrium, causing maternal deaths. Major risk factors include placenta previa and cesarean delivery, which is increasing without medical indication. This study was conducted with aim to explore the risk factors of PAS, clinical outcomes of affected patients, and strategies to minimize maternal morbidity and mortality.Materials and Methods: A total of 142 women who had undergone at least one cesarean delivery in the past were included. Among them, 85 women had placenta accreta spectrum (PAS) in their current pregnancy (group 1), while 57 did not have PAS (group 2). The information regarding their demographics and previous gynecological history, including placenta previa were collected. P<0.05 was considered statistically significant.Results: The risk of placenta accreta spectrum (PAS) is significantly higher in cases where there has been a previous cesarean delivery and placenta previa (p0.05). PAS was associated with more emergent cesarean deliveries (p<0.001) and hysterectomies (p<0.001). Moreover, 97% of patients with history of placenta previa developed PAS (p<0.001). Most of the patients who underwent hysterectomy had PAS and placenta previa (p0.05).Conclusion: Women with previous cesarean delivery are significantly at risk of placenta accreta in their future pregnancies. Pregnant women should avoid insisting on elective cesarean delivery without medical indication. Planned cesarean delivery could reduce the maternal complications.

1 January 2020 in Journal of Vessels and Circulation
Verified
Journal Article
Open access
PDF file
MAMohammad Hossein Arjmandnia
Mohammad Hossein Arjmandnia
MYMaryam Yousefi
Maryam Yousefi
SRSajad Rezvan
Sajad Rezvan
MVMostafa Vahedian
Mostafa Vahedian
ENEnayatollah Noori
Enayatollah Noori
FAFatemeh Amirkanian
Fatemeh Amirkanian
Background and Aim: Neonates of diabetic mothers are more prone to congenital heart diseases than others. These abnormalities are the leading cause of fetal death in diabetic neonates. Therefore, the determination of a screening method and evaluation of its value seems necessary in such neonates. The present study investigated the various ...

31 December 2025 in Journal of Obstetrics, Gynecology and Cancer Research
Verified
Journal Article
Open access
PDF file
MYMaryam Yousefi
Maryam Yousefi
ZKZahra Kamelian
Zahra Kamelian
MAMohammad Hosein Arjmandnia
Mohammad Hosein Arjmandnia
ENEnayatollah Noori
Enayatollah Noori
MPMohammadReza PourMahjoor
MohammadReza PourMahjoor
Background & Objective: Ovarian cysts are common findings in gynecological practice and are often detected incidentally through imaging, particularly ultrasound. This study was conducted with aim to evaluate the compatibility between preoperative ultrasound findings and final pathological diagnoses of ovarian.Materials & Methods: This study was conducted on the medical records of 100 patients who underwent surgical intervention for ovarian cysts in 2020 at Forghani Hospital, Qom, Iran. Variables included patient demographics, cyst characteristics (size, morphology, solid components, septations, Doppler vascularity), tumor markers (AFP, LDH, CA125, CEA, HE4, CA19.9), ultrasound impressions (benign vs. suspicious), and histopathological diagnoses. Statistical analysis was performed using SPSS software (version 26), and agreement between ultrasound and histopathology was assessed via the Kappa statistic and categorical variables compared using the Chi-square test. P<0.05 was considered significant. Results: Pathological diagnoses revealed 94% of cysts as benign lesions (28% functional cysts, 30% serous cysts, 18% dermoids, 18% endometriomas) and 6% malignant lesions. Ultrasound classified 45% of cysts as "benign" and 55% as "suspicious." A significant correlation was found between ultrasound impressions and pathology diagnosis (P<0.001). For malignancy detection, ultrasound demonstrated moderate sensitivity (50%), low specificity (44.7%), low positive predictive value (PPV: 5.5%), and high negative predictive value (NPV: 93.3%). Tumor markers showed elevated CA125 (42%) and HE4 (39%) in benign cases, highlighting limited specificity. Conclusion: Ultrasound effectively excludes benign ovarian cysts (high NPV) but poorly detects malignancy (low PPV). Integrated diagnostic approaches combining standardized systems, tumor markers, and advanced imaging are essential to improve risk assessment and avoid overtreatment.

30 June 2025 in Journal of Obstetrics, Gynecology and Cancer Research
Verified
Journal Article
Open access
PDF file
SASeyed Mojtaba Alavi
Seyed Mojtaba Alavi
SBSusan Belar
Susan Belar
SRSyeda Zainab Rizvi
Syeda Zainab Rizvi
SHSamaneh Hokmelahi
Samaneh Hokmelahi
AEAya Galal Elnagar
Aya Galal Elnagar
MYMaryam Yousefi
Maryam Yousefi
Background & Objective: Gynecological and breast cancers are responsible for a significant proportion of cancer-related mortalities. Recent evidence indicates that 15.25% of the 8.2 million new cancer cases are gynecological malignancies. To enhance patients' prognosis and quality of life, treatment approaches are continuously changing. This study is a narrative review investigating the latest applications of GnRH agonists for treating gynecological malignancies, specifically breast, ovarian, and endometrial cancers. Materials & Methods: A thorough review of the PubMed, Web of Science, and Google Scholar databases using the keywords ‘gonadotropin-releasing hormone agonists’, ‘GnRH agonists’, GnRH analogs’, gynecological cancers’, ‘gynecological malignancies’, and ‘Breast Cancer’ for articles published between 2017 and 2023 was conducted. Results: Recently, fertility preservation has become a vital concern in modern society. Therefore, GnRH agonists play a key role in protecting the ovarian function of young patients diagnosed with cancer, particularly those with breast or gynecological cancers who are undergoing chemotherapy. Conclusion: GnRH agonists can play a crucial role in the treatment course of gynecological malignancies, particularly those that are hormone sensitive

8 July 2026 in Oxford Medical Case Reports
Verified
Journal Article
Open access
MYMaryam Yousefi
Maryam Yousefi
EBElham Sadat Banimostafavi
Elham Sadat Banimostafavi
MGMahdiieh Ghoddoosi
Mahdiieh Ghoddoosi
Introduction: Struma ovarii is a rare monodermal teratoma composed predominantly of thyroid tissue. While typically benign, its clinical and radiological presentation can be highly deceptive, often mimicking a malignant ovarian tumor. Case Presentation: A 52-year-old postmenopausal Afghan woman presented with progressive abdominal distension, pelvic pain, severe ascites, and a complex, highly vascular right adnexal mass. Imaging (ORADS 5) and markedly elevated CA-125 suggested advanced ovarian carcinoma. Despite receiving seven cycles of carboplatin/paclitaxel chemotherapy for presumed primary peritoneal carcinoma, the mass and ascites persisted. Following laparotomy and left salpingo-oophorectomy, histopathology confirmed benign struma ovarii without peritoneal carcinomatosis. Postoperatively, ascites resolved and CA-125 normalized. The patient remained well with no recurrence at 14-month follow-up. Conclusion: This case underscores the critical importance of considering struma ovarii in the differential diagnosis of a complex ovarian mass, even when clinical features and tumor markers strongly suggest malignancy.

23 June 2024 in Fertility, Gynecology and Andrology
Verified
Journal Article
Open access
PDF file
MYMaryam Yousefi
Maryam Yousefi
MAMohammad Hossein Arjmandnia
Mohammad Hossein Arjmandnia
FAFaezeh Arjmandnia
Faezeh Arjmandnia
Introduction: COVID-19 infection in pregnant women can increase the risk of complications, particularly coagulation disorders and mortality. Case Presentation: We reported a case of a 32-year-old pregnant woman infected with COVID-19. One day after admission for COVID-19 treatment, she underwent a cesarean section (C/S). About 30 hours after the C/S, the patient's hemoglobin levels dramatically dropped. An emergency ultrasound revealed abundant free fluid in the abdomen. Based on the ultrasound findings, the patient underwent a diagnostic laparotomy. During the laparotomy, two liters of blood with clots were found in the abdomen, but the source of the bleeding was inconclusive. Following the laparotomy, the patient was transferred to the intensive care unit (ICU) and received necessary blood products such as packed cells, antihemophilic factor, and fresh frozen plasma (FFP). After five days, the patient was discharged in good general condition. Conclusions: Early diagnosis of bleeding, prompt and skilled interventions, and careful monitoring of recently operated pregnant women with COVID-19 reduce the risk of hemorrhagic shock, maternal complications, and mortality.